-
-
-
-
-
-
-
BofA Securities Upgrades Haemonetics (HAE) to Buy
-
-
-
-
-
-
-
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026
-
-
-
-
-
-
-
Haemonetics (HAE) Tops Q4 EPS by 2c, provides guidance
-
-
-
-
-
-
-
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025
-
-
-
-
-
-
-
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
-
-
-
-
-
-
-
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
-
-
-
-
-
-
-
Haemonetics Corporation Completes Acquisition of OpSens Inc.
-
1,217,550 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

